Related references
Note: Only part of the references are listed.Validation of the Inflammatory Bowel Disease Disability Index in a population-based cohort
Corinne Gower-Rousseau et al.
GUT (2017)
Patient-reported Outcomes in a French Nationwide Survey of Inflammatory Bowel Disease Patients
Nicolas Williet et al.
JOURNAL OF CROHNS & COLITIS (2017)
Comparison of health-related quality of life and disability in ulcerative colitis patients following restorative proctocolectomy with ileal pouch-anal anastomosis versus anti-tumor necrosis factor therapy
Sara van Gennep et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2017)
Development of the IBD Disk: A Visual Self-administered Tool for Assessing Disability in Inflammatory Bowel Diseases
Subrata Ghosh et al.
INFLAMMATORY BOWEL DISEASES (2017)
Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function
Daniel Ontaneda et al.
LANCET (2017)
Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study
Tomas Kalincik et al.
LANCET NEUROLOGY (2017)
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
X. Montalban et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Outcome Measures in Clinical Trials for Multiple Sclerosis
Caspar E. P. van Munster et al.
CNS DRUGS (2017)
Review article: moving towards common therapeutic goals in Crohn's disease and rheumatoid arthritis
P. B. Allen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Predictors of impaired quality of life in patients with rheumatic diseases
Panagiota Anyfanti et al.
CLINICAL RHEUMATOLOGY (2016)
Systematic review: outcomes and post-operative complications following colectomy for ulcerative colitis
L. Peyrin-Biroulet et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions
Laurent Peyrin-Biroulet et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Early Combined Immunosuppression in Crohn’s Disease: Acting Rather Than REACTing
Laurent Peyrin-Biroulet et al.
GASTROENTEROLOGY (2016)
The IBD Disability Index should become a Major Secondary Endpoint in Clinical Practice and in Clinical Trials
Laurent Peyrin-Biroulet et al.
JOURNAL OF CROHNS & COLITIS (2016)
Disability in Restorative Proctocolectomy Recipients Measured using the Inflammatory Bowel Disease Disability Index
Y. Lee et al.
JOURNAL OF CROHNS & COLITIS (2016)
Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial
Fred Lublin et al.
LANCET (2016)
Randomised clinical trial: deep remission in biologic and immunomodulator naive patients with Crohn's disease - a SONIC post hoc analysis
J. -F. Colombel et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Extraintestinal Manifestations of Inflammatory Bowel Disease
Stephan R. Vavricka et al.
INFLAMMATORY BOWEL DISEASES (2015)
Newly Developed Chronic Conditions and Changes in Health-Related Quality of Life in Postmenopausal Women
Juhua Luo et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2015)
Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial
Reena Khanna et al.
LANCET (2015)
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013
Theo Vos et al.
LANCET (2015)
Evaluation of No Evidence of Disease Activity in a 7-Year Longitudinal Multiple Sclerosis Cohort
Dalia L. Rotstein et al.
JAMA NEUROLOGY (2015)
Evolution of cost structures in rheumatoid arthritis over the past decade
Doerte Huscher et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Efficacy and safety of ascending methotrexate dose in combination with adalimumab: the randomised CONCERTO trial
Gerd-Rudiger Burmester et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Health-Related Quality of Life in Adult Survivors After the Fontan Operation
Manisha Kukreja et al.
SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY (2015)
Patient-Reported Outcomes as Primary End Points in Clinical Trials of Inflammatory Bowel Disease
Nicolas Williet et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targets
Daniel E. Furst et al.
RHEUMATOLOGY (2014)
Development and validation of a patient-reported disability measurement tool for patients with inflammatory bowel disease
P. B. Allen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Disease-Modifying Anti-Inflammatory Bowel Disease Drugs (DMAIDs): The Missing Term in the Literature
Laurent Peyrin-Biroulet
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
'Insights in the relationship of joint space narrowing versus erosive joint damage and physical functioning of patients with RA'
R. Koevoets et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Moving towards disease modification in inflammatory bowel disease therapy
Patrick B. Allen et al.
CURRENT OPINION IN GASTROENTEROLOGY (2013)
Determinants of fatigue in Crohn's disease patients
Lauran Vogelaar et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2013)
Early Administration of Azathioprine vs Conventional Management of Crohn's Disease: A Randomized Controlled Trial
Jacques Cosnes et al.
GASTROENTEROLOGY (2013)
Early Azathioprine Therapy Is No More Effective Than Placebo for Newly Diagnosed Crohn's Disease
Julian Panes et al.
GASTROENTEROLOGY (2013)
Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study
Marte Lie Hoivik et al.
GUT (2013)
Predictors of Temporary and Permanent Work Disability in Patients With Inflammatory Bowel Disease: Results of the Swiss Inflammatory Bowel Disease Cohort Study
Uwe Siebert et al.
INFLAMMATORY BOWEL DISEASES (2013)
Brain atrophy and lesion load predict long term disability in multiple sclerosis
Veronica Popescu et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Defining and scoring response to IFN-β in multiple sclerosis
Maria Pia Sormani et al.
NATURE REVIEWS NEUROLOGY (2013)
Gray matter damage predicts the accumulation of disability 13 years later in MS
Massimo Filippi et al.
NEUROLOGY (2013)
Gastrointestinal and Psychological Mediators of Health-Related Quality of Life in IBS and IBD: A Structural Equation Modeling Analysis
Bruce D. Naliboff et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Development of the Paris Definition of Early Crohn's Disease for Disease-Modification Trials: Results of an International Expert Opinion Process
Laurent Peyrin-Biroulet et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Comparative effectiveness and safety of biological treatment options after tumour necrosis factor α inhibitor failure in rheumatoid arthritis: systematic review and indirect pairwise meta-analysis
Monika Schoels et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Deep Remission: A New Concept?
Jean-Frederic Colombel et al.
DIGESTIVE DISEASES (2012)
Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health
Laurent Peyrin-Biroulet et al.
GUT (2012)
Chronic fatigue is associated with impaired health-related quality of life in inflammatory bowel disease
L. -P. Jelsness-Jorgensen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Physical disability in rheumatoid arthritis is associated with cartilage damage rather than bone destruction
Daniel Aletaha et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials
David T. Felson et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
A Population-based Study of Fatigue and Sleep Difficulties in Inflammatory Bowel Disease
Lesley A. Graff et al.
INFLAMMATORY BOWEL DISEASES (2011)
MECHANISMS OF DISEASE The Pathogenesis of Rheumatoid Arthritis
Iain B. McInnes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Measures of Functional Status and Quality of Life in Rheumatoid Arthritis Health Assessment Questionnaire Disability Index (HAQ), Modified Health Assessment Questionnaire (MHAQ), Multidimensional Health Assessment Questionnaire (MDHAQ), Health Assessment Questionnaire II (HAQ-II), Improved Health Assessment Questionnaire (Improved HAQ), and Rheumatoid Arthritis Quality of Life (RAQoL)
Leann Maska et al.
ARTHRITIS CARE & RESEARCH (2011)
Increased Response and Remission Rates in Short-Duration Crohn's Disease With Subcutaneous Certolizumab Pegol: An Analysis of PRECiSE 2 Randomized Maintenance Trial Data
Stefan Schreiber et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Evidence for treating rheumatoid arthritis to target: results of a systematic literature search
Monika Schoels et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Treating rheumatoid arthritis to target: recommendations of an international task force
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
'Treat to target': moving targets from hypertension, hyperlipidaemia and diabetes to rheumatoid arthritis
Dan Atar et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
2010 Rheumatoid Arthritis Classification Criteria An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
Daniel Aletaha et al.
ARTHRITIS AND RHEUMATISM (2010)
Risk Factors Associated With Progression to Intestinal Complications of Crohn's Disease in a Population-Based Cohort
Kelvin T. Thia et al.
GASTROENTEROLOGY (2010)
Disability in Inflammatory Bowel Diseases: Developing ICF Core Sets for Patients with Inflammatory Bowel Diseases Based on the International Classification of Functioning, Disability, and Health
Laurent Peyrin-Biroulet et al.
INFLAMMATORY BOWEL DISEASES (2010)
Fatigue and Health-related Quality of Life in Inflammatory Bowel Disease: Results from a Population-Based Study in the Netherlands: The IBD-South Limburg Cohort
M. J. L. Romberg-Camps et al.
INFLAMMATORY BOWEL DISEASES (2010)
Rituximab in Patients with Primary Progressive Multiple Sclerosis Results of a Randomized Double-Blind Placebo-Controlled Multicenter Trial
Kathleen Hawker et al.
ANNALS OF NEUROLOGY (2009)
Depresión y ansiedad en la enfermedad inflamatoria intestinal
Gabriele Moser
Gastroenterologia y Hepatologia (2009)
Pain and Inflammatory Bowel Disease
Klaus Bielefeldt et al.
INFLAMMATORY BOWEL DISEASES (2009)
Level of radiographic damage and radiographic progression are determinants of physical function: a longitudinal analysis of the TEMPO trial
D. van der Heijde et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease
S. Kugathasan et al.
GUT (2007)
Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial)
S. M. M. Verstappen et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Crohn's disease, fatigue, and infliximab: Is there a role for cytokines in the pathogenesis of fatigue?
Itta M. Minderhoud et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Validation of the International Classification of Functioning, Disability and Health (ICF) Core Set for rheumatoid arthritis from the patient perspective using focus groups
Michaela Coenen et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Quality of life after proctocolectomy with lleoanal anastomosis for patients with ulcerative colitis
Gary R. Lichtenstein et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2006)
Inflammatory bowel disease in Iran: A review of 457 cases
R Aghazadeh et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial
C Grigor et al.
LANCET (2004)
Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission
ETH Molenaar et al.
ARTHRITIS AND RHEUMATISM (2004)
Share Paper
